Sherger M, Kisseberth W, London C, Olivo-Marston S, Papenfuss TLIdentification of myeloid derived suppressor cells in the peripheral blood of tumor bearing dogs.BMC Vet Res 8 209 10/31/2012
London C, Mathie T, Stingle N, Clifford C, Haney S, Klein MK, Beaver L, Vickery K, Vail DM, Hershey B, Ettinger S, Vaughan A, Alvarez F, Hillman L, Kiselow M, Thamm D, Higginbotham ML, Gauthier M, Krick E, Phillips B, Ladue T, Jones P, Bryan J, Gill V, Novasad A, Fulton L, Carreras J, McNeill C, Henry C, Gillings SPreliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.Vet Comp Oncol 10(3) 194-205 9/1/2012
Robat C, London C, Bunting L, McCartan L, Stingle N, Selting K, Kurzman I, Vail DMSafety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.Vet Comp Oncol 10(3) 174-83 9/1/2012
Vail DM, von Euler H, Rusk AW, Barber L, Clifford C, Elmslie R, Fulton L, Hirschberger J, Klein M, London C, Martano M, McNiel EA, Morris JS, Northrup N, Phillips B, Polton G, Post G, Rosenberg M, Ruslander D, Sahora A, Siegel S, Thamm D, Westberg S, Winter J, Khanna CA randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs.J Vet Intern Med 26(3) 598-607 5/1/2012
Wasserman J, Diese L, Vangundy Z, London C, Carson WE, Papenfuss TLSuppression of canine myeloid cells by soluble factors from cultured canine tumor cells.Vet Immunol Immunopathol 145(1-2) 420-30 1/15/2012